Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Joseph Saad

8PUBLICATIONS

80CO-AUTHORS

Gene and molecular therapyPredictive and prognostic markersNeonatologyCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Jan 14, 2026

Drivers of clinical resistance to venetoclax and hypomethylating agents in acute myeloid leukemia and strategies for improving efficacy.

Ida Vänttinen, Joseph Saad, Tanja Ruokoranta

|Sep 21, 2025

Predictors of response and rational combinations for the novel MCL-1 inhibitor MIK665 in acute myeloid leukemia.

Joseph Saad, Rhiannon Newman, Elmira Khabusheva

|Apr 09, 2025

DEK::NUP214 acts as an XPO1-dependent transcriptional activator of essential leukemia genes.

Fadimana Kaya, Findlay Bewicke-Copley, Juho J Miettinen

|Oct 02, 2024

Ex vivo venetoclax sensitivity predicts clinical response in acute myeloid leukemia in the prospective VenEx trial.

Sari Kytölä, Ida Vänttinen, Tanja Ruokoranta

|Jan 10, 2024

Monosomy 7/del(7q) cause sensitivity to inhibitors of nicotinamide phosphoribosyltransferase in acute myeloid leukemia.

Samuli Eldfors, Joseph Saad, Nemo Ikonen

|Dec 12, 2022

Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia.

Heikki Kuusanmäki, Olli Dufva, Markus Vähä-Koskela

Pageof 2

Frequent Collaborators

8 joint publications

Caroline A Heckmann

4 joint publications

Mika Kontro

3 joint publications

Kimmo Porkka

3 joint publications

Heikki Kuusanmäki

2 joint publications

Juho Miettinen

2 joint publications

Samuli Eldfors

2 joint publications

Tanja Ruokoranta

2 joint publications

Markus Vähä-Koskela

2 joint publications

Ida Vänttinen

1 joint publications

Vésteinn Thorsson

Frequent Collaborators

8 joint publications

Caroline A Heckmann

4 joint publications

Mika Kontro

3 joint publications

Kimmo Porkka

3 joint publications

Heikki Kuusanmäki

Top Related Videos

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on : Jun 17, 2022

Investigation of the Transcriptional Role of a <em>RUNX1</em> Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Investigation of the Transcriptional Role of a <em>RUNX1</em> Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Published on : Sep 01, 2019

See more related videos

Top Related Videos

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on : Jun 17, 2022

Investigation of the Transcriptional Role of a <em>RUNX1</em> Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Investigation of the Transcriptional Role of a <em>RUNX1</em> Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Published on : Sep 01, 2019

See more related videos